| 產(chǎn)品編號(hào) | bs-0917R |
| 英文名稱 | Rabbit Anti-BrdU(Proliferation Marker) antibody |
| 中文名稱 | 5-溴脫氧尿嘧啶核苷（增殖標(biāo)志物）抗體 |
| 別 名 | Bromodeoxyuridine; Bromodeoxyuridine; 5-Bromo-2′-deoxyuridine; 5-BrdU; Proliferation Marker; 5-Bromo-2-deoxyUridine. |
 |
Specific References (3) | bs-0917R has been referenced in 3 publications.
[IF=6.656] Wei Hao. et al. Classical prescription Huanglian Decoction relieves ulcerative colitis via maintaining intestinal barrier integrity and modulating gut microbiota. PHYTOMEDICINE. 2022 Sep;:154468 IF ; Mouse.
[IF=5.195] Lu Hong. et al. Investigation of Naoluoxintong on the neural stem cells by facilitating proliferation and differentiation in vitro and on protecting neurons by up-regulating the expression of nestin in MCAO rats. J ETHNOPHARMACOL. 2022 Sep;:115684 IF ; Rat.
[IF=3.659] Wang, Xiao-feng. et al. Active constituent of Polygala tenuifolia attenuates cognitive deficits by rescuing hippocampal neurogenesis in APP/PS1 transgenic mice. Bmc Complem Altern M. 2021 Dec;21(1):1-15 IF ; Mouse.
|
| 產(chǎn)品類型 | 小分子抗體 |
| 研究領(lǐng)域 | 細(xì)胞生物 發(fā)育生物學(xué) 染色質(zhì)和核信號(hào) 神經(jīng)生物學(xué) 細(xì)胞凋亡 細(xì)胞周期蛋白 藥物及化合物 細(xì)胞類型標(biāo)志物 |
| 抗體來(lái)源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Human,Rat,BrdU) |
| 產(chǎn)品應(yīng)用 | ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | .3071kDa |
| 細(xì)胞定位 | 細(xì)胞核 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated Brdu |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Bromodeoxyuridine (BrdU) is a thymidine analog and is specifically incor-porated into DNA during DNA synthesis. Anti-bromodeoxyuridine monoclonal antibody is used to identify cells that have incorporated BrdU. This immunological detection scheme has several advantages over the use of radioactive thymidine incorporation for identifying cells under-going replication. Labeling and detection can be performed the same day instead of waiting several days, as required for autoradiography of tritium-labeled cells, and the necessity of using multiple specimens for obtaining the optimal exposure time is eliminated. In addition, anti-bromodeoxyuridine staining with flow cytometric analysis allows multiple parameters to be evaluated simultaneously. Anti-bromodeoxyuridine monoclonal antibody has been used for identi-fying proliferating cells in blood (Campana et al., 1988), tissues (Schutte et al., 1987; Hayashi, et al., 1988), tumors (Hoshino et al., 1986; Morstyn et al., 1983), as well as for determining plasma cell labeling indices (Greipp et al., 1985). Subcellular Location: Nuclear. SWISS: N/A CAS: 59-14-3 BrdU（溴化脫氧尿嘧啶核苷）可以在體內(nèi)和體外摻入到處于S期的細(xì)胞所合成的DNA鏈中。此抗體可以與摻入到任何種屬細(xì)胞中的BrdU反應(yīng)，與碘脫氧尿嘧啶有交叉反應(yīng)，標(biāo)記摻有BrdU的S期細(xì)胞，主要用于研究各種不同的因素對(duì)正常/腫瘤組織的細(xì)胞增殖及動(dòng)力學(xué)的研究。 用FITC標(biāo)記的抗BrdU IgG可用于流式細(xì)胞術(shù)定量檢測(cè)增值細(xì)胞。 |
